2014, № 12 (173)

1. Mikhailova, M.A. Features of the development of occlusive vascular lesions of the retina and the optic nerve on the background of cardio-vascular diseases / M.A. Mikhailova, A.A. Plyuhova, N.V. Balatskaya, M.V. Budzinskaya // Practical medicine. — 2012. — T.2. — P. 71–74.

2. Tankovskiy, V.E. Retinal vein thrombosis / V.E. Tankovskiy. — M., 2000.

3. Tultseva, S.N. Retinal vein occlusion (etiology, pathogenesis, clinical features, diagnosis, treatment) / S.N. Tultseva, Y.S. Astakhov // — St. Petersburg. "Publ H-L", 2010. — 112 p.

4. Tultseva, S.N. Anatomic and hemodynamic conditions of retinalvein occlusion / S.N. Tultseva // Ophthalmic vedomosti. — 2011.– Volume IV, №4. — P. 70–76.

5. Khokhlova, D.Y. Analysis of systemic risk factors in patients with retinal vein occlusion / D.Y. Khokhlova, E.A. Drozdova // Medical vetsnik Bashkortostana. — 2014. — Volume 9, №2. — P. 144–147.

6. Heier, S. Ranibizumab for macular edema due to retinal vein occlusions / S. Heier, P. Campochiaro [et al.] // Ophthalmology. — 2012. — P. 802–809.

7. Kida, T. Treatment of cystemic hypertention is important for improvement of macular edema associated with retinal vein occlusions / T. Kida., S. Morishita [et al.] // Clinical Ophthalmology. — 2014. — P. 955–958.

8. Keane, P. Retinal vein occlusion and macular edema — critical evaluation of the clinical value of ranibizumab / P. Keane, R. Sadda // Clinical Ophthalmology. — 2011. — P. 771–781

9. Martin, S.C. Cardiovascular risk assessment in patients with retinal vein occlusion / S.C. Martin, A. Butcher [et al.] // Br. J. Ofhtalmol. — 2002. — Vol. 86, №7. — Р. 774–776

10. Pieramici, D.J. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions / D.J. Pieramici, M. Rabena, A.A. Castellatin [et al.] // Ophthalmology. — 2008. — Vol. 115 (10). — P. 47–54.

11. Stefansson, E. Treatment of branch retinal vein occlusion / Е. Stefansson // ActaOphthalmol. — 2008. — Vol. 86, №1. — P. 122–123.

About this article